ClassID:

20298

A61K31/365 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin Lactones

Recent Application in this class:
#301
20220257692
2022-08-18

Compositions and methods for supporting immune health

#302
20220257652
2022-08-18

METHODS OF USE FOR CAR T CELLS

#303
20220257583
2022-08-18

Compositions and Methods for the Treatment of Intracranial Diseases

#304
20220257576
2022-08-18

METHODS AND COMPOSITIONS FOR TREATING OBESITY AND/OR DIABETES AND FOR IDENTIFYING CANDIDATE TREATMENT AGENTS

#305
20220257555
2022-08-18

Derivatives of korormicin useful as antibiotics

#306
20220257515
2022-08-18

Drug delivery methods and compositions

#307
20220249435
2022-08-11

Applications of Butyrolactone-I in Preparing Medicine for Preventing Neuroinflammation and/or Memory and Cognitive Disorders

#308
20220233697
2022-07-28

METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING INEFFECTIVE ERYTHROPOIESIS

#309
20220233463
2022-07-28

LOCAL ANESTHETIC COMPRISING A TRP CHANNEL MODULATOR

#310
20220226284
2022-07-21

Methods for the treatment of infections

#311
20220226281
2022-07-21

COMPOUNDS FOR USE IN ANTI-CANCER IMMUNOTHERAPY

#312
20220220412
2022-07-14

MUSK COMPOSITIONS AND METHODS OF USE THEREOF

#313
20220218731
2022-07-14

COMBINATION THERAPIES FOR CANCER TREATMENT

#314
20220218659
2022-07-14

PI3K/LYN-ACLY Signaling Inhibition

#315
20220211669
2022-07-07

Methods, agents, and compositions for the treatment of acute myeloid leukemia

#316
20220211664
2022-07-07

LYMPH DIRECTING PRODRUGS

#317
20220211663
2022-07-07

NANO CO-DELIVERY OF QUERCETIN AND ALANTOLACTONE PROMOTES ANTI-TUMOR RESPONSE THROUGH SYNERGISTIC IMMUNOGENIC CELL DEATH FOR MICROSATELLITE-STABLE COLORECTAL CANCER

#318
20220205999
2022-06-30

METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE IN COMPANION ANIMALS

#319
20220202938
2022-06-30

TRANSDERMAL FORMULATIONS

#320
20220202770
2022-06-30

COMPOSITION FOR TREATING HEPATITIS B, AND METHOD FOR EVALUATING REPLICATION ACTIVITY OF HEPATITIS B VIRUS

#321
20220202739
2022-06-30

ENDOCANNABINOID MIMETIC AND ANTI-INFLAMMATORY COMPOUND CONTAINING COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF

#322
20220193030
2022-06-23

USE OF GINKGO TERPENE LACTONE IN PREPARING DRUG FOR PREVENTING AND/OR TREATING GUILLAIN-BARRE-STROHL SYNDROME

#323
20220193029
2022-06-23

BRYOSTATIN COMPOUNDS FOR ENHANCEMENT OF IMMUNOTHERAPY

#324
20220184111
2022-06-16

METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY

#325
20220184039
2022-06-16

Ophthalmic pharmaceutical compositions and uses relating thereto

#326
20220184028
2022-06-16

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING PKC ACTIVATORS

#327
20220160804
2022-05-26

USE OF LAURUS NOBILIS EXTRACT FRACTIONS TO PROTECT AGAINST AIR POLLUTION RELATED DISEASES

#328
20220160714
2022-05-26

METHODS FOR TREATING COLORECTAL CANCER

#329
20220152228
2022-05-19

COMPOSITIONS AND METHODS FOR RADIOTHERAPY USING CHELATED RADIOTHERAPEUTIC AGENTS AND NON-TARGET TISSUE BLOCKADE

#330
20220143128
2022-05-12

METHODS FOR TREATING TRAUMATIC BRAIN INJURY

#331
20220142984
2022-05-12

Soft Chewable Pharmaceutical Products

#332
20220142972
2022-05-12

PARASITICIDAL FORMULATIONS AND USE THEREOF

#333
20220142934
2022-05-12

COMBINATION THERAPEUTICS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE AND OTHER DISEASES

#334
20220135695
2022-05-05

ANTI-CD38 AGENTS FOR DESENSITIZATION AND TREATMENT OF ANTIBODY-MEDIATED REJECTION OF ORGAN TRANSPLANTS

#335
20220133688
2022-05-05

MACROCYCLIC LACTONE ANTHELMINTICS AGAINST NEMATODES

#336
20220133687
2022-05-05

METHODS OF TREATING AND PREVENTING NEURODEGENERATIVE DISEASES WITH HGF ACTIVATING COMPOUNDS

#337
20220125816
2022-04-28

Compositions and methods for the treatment of AUD

#338
20220125783
2022-04-28

Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization

#339
20220125773
2022-04-28

AQUEOUS FORMULATIONS OF WATER INSOLUBLE COX-2 INHIBITORS

#340
20220125728
2022-04-28

Strategies to enhance lung cancer treatment

#341
20220118035
2022-04-21

PHARMACEUTICAL DELIVERY COMPOSITIONS AND USES THEREOF

#342
20220117927
2022-04-21

Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors

#343
20220112173
2022-04-14

Treprostinil derivative compounds and methods of using same

#344
20220111050
2022-04-14

Biophotonic compositions, methods, and kits for inhibiting and disrupting biofilms

#345
20220105059
2022-04-07

METHOD OF TREATING OR PREVENTING NEURODEGENERATION

#346
20220096431
2022-03-31

PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTING, TREATING AND DIAGNOSING A NEURODEGENERATIVE DISEASE

#347
20220096430
2022-03-31

Devices and methods for facilitating and controlling use of a medication

#348
20220090085
2022-03-24

Compositions and methods for reactivating latent immunodeficiency virus

#349
20220087992
2022-03-24

Compounds and methods of treating retinal degeneration

#350
20220080005
2022-03-17

GINKGO BILOBA LEAVE EXTRACT CAPSULE AND PREPARATION METHOD THEREFOR

#351
20220071941
2022-03-10

THERAPIES FOR SQUAMOUS CELL CARCINOMAS

#352
20220062366
2022-03-03

FEIJOA FRUIT EXTRACT

#353
20220054450
2022-02-24

STABLE CANNABINOID FORMULATIONS

#354
20220047542
2022-02-17

NOVEL DOSAGE FORMS OF ROFECOXIB AND RELATED METHODS

#355
20220040147
2022-02-10

Short syntheses of (−)-picrotoxinin and related compounds

#356
20220031721
2022-02-03

Skin barrier composition

#357
20220023329
2022-01-27

Edible Energy Composition

#358
20220016127
2022-01-20

COMPOSITIONS AND METHODS FOR INDUCING APPENDAGE AND LIMB REGENERATION

#359
20220016116
2022-01-20

DETERMINING DRUG COMBINATIONS, SYNERGISTIC DRUG COMBINATION AND USE THEREOF IN PANCREATIC CANCER TREATMENT

#360
20220016075
2022-01-20

METHODS FOR THE TREATMENT OF MYCOBACTERIUM INFECTIONS

#361
20220008534
2022-01-13

Combination Of Local And Systemic Immunomodulative Therapies For Enhanced Treatment of Cancer

#362
20220002502
2022-01-06

Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation

#363
20220002396
2022-01-06

METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS

#364
20210401750
2021-12-30

Nanoparticles and nanonetworks formed therefrom

#365
20210393580
2021-12-23

PROCYANIDINS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION TRIGGERED BY COVID-19

#366
20210369731
2021-12-02

Covalent targeting of E3 ligases

#367
20210361575
2021-11-25

LIPID PRODRUGS FOR USE IN DRUG DELIVERY

#368
20210353666
2021-11-18

Enhanced Immune Response upon Treatment with Nitric Oxide

#369
20210353590
2021-11-18

BIOACTIVE FORMULATION AND METHOD FOR PREPARATION THEREOF

#370
20210353509
2021-11-18

STOMA POWDER INCLUDING SKIN HEALTH INGREDIENTS

#371
20210346354
2021-11-11

MACROPINOCYTOSIS IN CANCER

#372
20210338690
2021-11-04

COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF CORONAVIRUS INFECTIONS

#373
20210337794
2021-11-04

Antimicrobial, disinfecting, and wound healing compositions and methods for producing and using the same

#374
20210330677
2021-10-28

PKC INHIBITORS FOR THE TREATMENT OF SEPTIC CHOLESTASIS WITH CTM TARGETING

#375
20210330641
2021-10-28

Pharmaceutical Preparations

#376
20210330632
2021-10-28

Methods for treating obesity

#377
20210330611
2021-10-28

THERAPY FOR NEUROLOGICAL DISEASES/DISORDERS

#378
20210324074
2021-10-21

Affinity matured CD22-specific monoclonal antibody and uses thereof

#379
20210317079
2021-10-14

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α

#380
20210315941
2021-10-14

RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS

#381
20210315831
2021-10-14

PREPARATION OF NANOSUSPENSION COMPRISING NANOCRYSTALS OF ACTIVE PHARMACEUTICAL INGREDIENTS WITH LITTLE OR NO STABILIZING AGENTS

#382
20210315816
2021-10-14

ANTIMICROBIAL COMPOSITIONS AND METHODS

#383
20210308099
2021-10-07

METHODS AND COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS

#384
20210299269
2021-09-30

Splicing modulator antibody-drug conjugates and methods of use

#385
20210299118
2021-09-30

Coordinated metabolic reprogramming in response to productive viral infections

#386
20210292309
2021-09-23

Bryostatin compounds and methods of preparing the same

#387
20210290779
2021-09-23

DIAGNOSIS AND TREATMENT FOR RESPIRATORY TRACT DISEASES

#388
20210284988
2021-09-16

Reprogramming urokinase into an antibody-recruiting anticancer agent

#389
20210283160
2021-09-16

Viral inhibition

#390
20210283099
2021-09-16

CDC7 kinase inhibitors and uses thereof

#391
20210277328
2021-09-09

Musk compositions and methods of use thereof

#392
20210275626
2021-09-09

Use of an ABC transporter peptide inhibitor

#393
20210269453
2021-09-02

Bryoid compositions, methods of making and use thereof

#394
20210261594
2021-08-26

USE OF AVERMECTIN DERIVATIVE FOR INCREASING BIOAVAILABILITY AND EFFICACY OF MACROCYLIC LACTONES

#395
20210260144
2021-08-26

QUININE AND ITS USE TO GENERATE INNATE IMMUNE RESPONSE

#396
20210251900
2021-08-19

COMPOSITIONS AND METHODS FOR DRUG DELIVERY

#397
20210236450
2021-08-05

Methods and Compositions for Preventing and Treating Auditory Dysfunctions

#398
20210230176
2021-07-29

Hepatitis B antiviral agents

#399
20210220360
2021-07-22

Palatable antiparasitic formulations

#400
20210205392
2021-07-08

Anisomeles indica extract composition for Treating or Improving Gastric Ulcer

#401
20210205286
2021-07-08

Methods and compositions for treating autophagy related disease states and conditions utilizing AMPK activation

#402
20210205266
2021-07-08

MRSA biofilm inhibition

#403
20210196773
2021-07-01

Ginkgo diterpene lactone composition

#404
20210196754
2021-07-01

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#405
20210196676
2021-07-01

TREATMENT OF VIRAL INFECTIONS AND VIRALLY ASSOCIATED LESIONS WITH SEQUITERPENE LACTONES

#406
20210196675
2021-07-01

USE OF GINKGO BILOBA TERPENE LACTONE IN PREPARATION OF DRUGS FOR PREVENTION AND/OR TREATMENT OF TREMORS AND HEALTHCARE PRODUCTS

#407
20210196674
2021-07-01

Therapeutics for Malaria

#408
20210186926
2021-06-24

Carolacton and derivatives thereof for use in the treatment of cell proliferation disorders

#409
20210177808
2021-06-17

INJECTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND THEIR USE AGAINST PARASITE INFESTATION

#410
20210177749
2021-06-17

Solid oral pharmaceutical compositions for isoxazoline compounds

#411
20210170026
2021-06-10

ANTICANCER AGENT, RADIOSENSITIZER, AND FOOD COMPOSITION

#412
20210169845
2021-06-10

NOVEL DOSAGE FORMS OF ROFECOXIB AND RELATED METHODS

#413
20210169838
2021-06-10

Novel class of compounds for the treatment of cardiovascular disease.

#414
20210161982
2021-06-03

Pharmaceutical composition and use thereof for ischemia treatment

#415
20210161954
2021-06-03

Universal anti-CD22 chimeric antigen receptor engineered immune cells

#416
20210161931
2021-06-03

Bile acid synthesis promoter, composition for promoting bile acid synthesis and food composition for promoting bile acid synthesis

#417
20210145899
2021-05-20

Antifungal and antimicrobial uses of containing compositions

#418
20210138214
2021-05-13

Devices and methods for the treatment of body surface disorders

#419
20210138075
2021-05-13

CELL INTERNALIZING COMPOUNDS

#420
20210137934
2021-05-13

METHODS OF IDENTIFYING MYC-DRIVEN AND LIPOGENESIS-DEPENDENT NEOPLASMS AND METHODS OF TREATING THE SAME

#421
20210137878
2021-05-13

NOVEL DOSAGE FORMS OF ROFECOXIB AND RELATED METHODS

#422
20210130867
2021-05-06

NOVEL KINASE FOR TREATING AND PREVENTING FUNGAL INFECTIONS, AND USE THEREOF

#423
20210128498
2021-05-06

Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide

#424
20210121469
2021-04-29

Edible Energy Composition

#425
20210113715
2021-04-22

TARGETED NANOPARTICLES FOR DIAGNOSING, DETECTING AND TREATING CANCER

#426
20210113596
2021-04-22

Glycan therapeutics and method of treating conditions associated with TMAO

#427
20210113573
2021-04-22

COMPOSITIONS AND METHODS TO PROMOTE THYMIC REGENERATION

#428
20210113555
2021-04-22

COMBINATIONS FOR THE TREATMENT OF CANCER

#429
20210101888
2021-04-08

Splicing modulator antibody-drug conjugates and methods of use

#430
20210100839
2021-04-08

Universal chimeric antigen receptor T cells specific for CD22

#431
20210093884
2021-04-01

Photodynamic therapy technique for preventing damage to the fovea of the eye or another body portion of a patient

#432
20210093658
2021-04-01

Methods and compositions for the treatment of pain and/or inflammation

#433
20210085663
2021-03-25

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS

#434
20210077517
2021-03-18

Edible Energy Composition

#435
20210077436
2021-03-18

Method of treating or preventing neurodegeneration

#436
20210069230
2021-03-11

SYNERGISTIC DRUG COMBINATIONS PREDICTED FROM GENOMIC FEATURES AND SINGLE-AGENT RESPONSE PROFILES

#437
20210069185
2021-03-11

USE OF FLIBANSERIN IN THE TREATMENT OF OBESITY

#438
20210069148
2021-03-11

Gingko diterpene lactone composition

#439
20210069083
2021-03-11

METHOD FOR IMPROVING SKIN WHITENING POWER OF A SKIN WHITENING AGENT

#440
20210069016
2021-03-11

Neurodegenerative Disorder Treatment Method

#441
20210060042
2021-03-04

Patentiflorin A analogs as antiviral agents

#442
20210059966
2021-03-04

Neprilysin inhibitors

#443
20210052602
2021-02-25

Compositions and methods for pain management

#444
20210052526
2021-02-25

METHOD OF TREATING OR PREVENTING NEURODEGENERATION

#445
20210038565
2021-02-11

Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections

#446
20210038563
2021-02-11

NEW SPIRONOLACTONE FORMULATIONS AND THEIR USE

#447
20210030836
2021-02-04

Tumor microenvironment-related target TAK1 and application thereof in inhibition of tumor

#448
20210030775
2021-02-04

Treatment of hearing loss

#449
20210025001
2021-01-28

Methods for Detecting and Treating Idiopathic Pulmonary Fibrosis

#450
20210023048
2021-01-28

Dosing regimens of PKC activators

#451
20210008074
2021-01-14

Biomarkers of methotrexate-induced immune tolerance

#452
20210000821
2021-01-07

Use of fatty acid oxidation inhibitors as antimicrobials

#453
20210000787
2021-01-07

Quercetin-based composition for treating rhinosinusitis

#454
20200405538
2020-12-31

Ocular device delivery methods and systems

#455
20200397905
2020-12-24

KRILL OIL FOR SOLUBILIZING POORLY WATER-SOLUBLE DIETARY SUPPLEMENTS AND PHARMACEUTICALLY ACTIVE AGENTS

#456
20200390852
2020-12-17

Compositions and methods for treating peripheral nerve disease, disorders, and injuries

#457
20200385489
2020-12-10

USING COLIPASE INHIBITORS TO TREAT PANCREATITIS

#458
20200384078
2020-12-10

Use of autoinducer-related pathway in inducing apoptosis and anti-infective therapy

#459
20200370045
2020-11-26

METHOD OF TREATING TYPE II DIABETES AND OBESITY AND METHOD OF SCREENING A MEDICAMENT FOR THE SAME

#460
20200360290
2020-11-19

Oral compositions and the preparation methods thereof

#461
20200353057
2020-11-12

REDUCING IMMUNOGENICITY TO PEGLOTICASE

#462
20200352918
2020-11-12

COMPOUNDS AND METHODS FOR TREATING OR PREVENTING FIBROSIS

#463
20200345686
2020-11-05

COMPOSITIONS AND METHODS FOR TREATING SKIN AND NEUROPATHIC CONDITIONS AND DISORDERS

#464
20200345682
2020-11-05

Derivatives of korormicin useful as antibiotics

#465
20200338085
2020-10-29

Edible Energy Composition

#466
20200338036
2020-10-29

Methods and compositions for increasing the potency of antifungal agents

#467
20200332222
2020-10-22

MUSK COMPOSITIONS AND METHODS OF USE THEREOF

#468
20200330400
2020-10-22

METHODS FOR THE TREATMENT OF CANCER USING COENZYME Q10 AND FATTY ACID METABOLISM INHIBITORS

#469
20200323844
2020-10-15

Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization

#470
20200323817
2020-10-15

Methods for inducing synaptogenesis with synaptic growth factor activating compounds

#471
20200297693
2020-09-24

GLUCOSE CONJUGATES OF TRIPTOLIDE, ANALOGS AND USES THEREOF

#472
20200277611
2020-09-03

PRESERVATION OF THE NEUROMUSCULAR JUNCTION AFTER TRAUMATIC NERVE INJURY

#473
20200276231
2020-09-03

ENHANCED ANTIVIRULENT FOR ANTIBIOTIC-RESISTANT BACTERIA

#474
20200276181
2020-09-03

THIENOISOQUINOLINES AND THEIR DERIVATIVES FOR TARGETING TUBULIN, CH-TOG, AURORA A KINASE, TPX2, CDK5RAP2 AND/OR ASPM

#475
20200268707
2020-08-27

METHODS OF MODULATING PROTEIN EXOCYTOSIS AND USES OF SAME IN THERAPY

#476
20200261878
2020-08-20

Extended release microparticles comprising drug, and preparation method therefor

#477
20200261523
2020-08-20

Pharmaceutical composition for preventing and treating alpha herpes virus infection, containing, as active ingredient, extract or fraction thereof

#478
20200261445
2020-08-20

USE OF SENOLYTIC AGENTS TO ELIMINATE PERSISTENT HIV RESERVOIRS

#479
20200261434
2020-08-20

IDH1 INHIBITORS FOR THE TREATMENT OF HAEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS

#480
20200255603
2020-08-13

Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation

#481
20200254015
2020-08-13

Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts

#482
20200230125
2020-07-23

PIM kinase inhibitors in combination with autophagy inhibitors for treatment of cancers

#483
20200230119
2020-07-23

Compounds and methods of treating retinal degeneration

#484
20200230063
2020-07-23

Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders

#485
20200222485
2020-07-16

MEDICINAL AMBROSIA PLANT EXTRACTS

#486
20200222439
2020-07-16

BILE ACID SYNTHESIS PROMOTER, COMPOSITION FOR PROMOTING BILE ACID SYNTHESIS AND FOOD COMPOSITION FOR PROMOTING BILE ACID SYNTHESIS

#487
20200222438
2020-07-16

Skin barrier composition

#488
20200222369
2020-07-16

Ophthalmic pharmaceutical compositions and uses relating thereto

#489
20200206167
2020-07-02

INHIBITOR OF TRPM-4 ION CHANNEL FOR TREATING OR PREVENTING NEURODEGENERATION

#490
20200199146
2020-06-25

Transplantation Therapies

#491
20200199145
2020-06-25

Transplantation Therapies

#492
20200199143
2020-06-25

Hepatitis B antiviral agents

#493
20200197893
2020-06-25

Apparatus for a mass production of monodisperse biodegradeable polymer-based microspheres and a multi-channel forming device incorporatable therein

#494
20200190593
2020-06-18

SPLICEOSOME MUTATIONS AND USES THEREOF

#495
20200188466
2020-06-18

COMPOSITIONS OF SCHISANDRA EXTRACTS AND METHODS THEREOF

#496
20200188407
2020-06-18

Compounds and methods for inducing chondrogenesis

#497
20200179423
2020-06-11

Use of secoisolariciresinol diglucosides (SDGS) and related compounds for protection against radiation and chemical damage

#498
20200179345
2020-06-11

PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF

#499
20200171114
2020-06-04

COMPOSITION FOR TREATING BENIGN PROSTATE HYPERPLASIA AND FUNCTIONAL HEALTH FOOD COMPRISING AUCKLANDIAE RADIX EXTRACT AND COSTUNOLIDE AS ACTIVE INGREDIENTS

#500
20200170996
2020-06-04

Use of a composition comprising 7-hydroxymatairesinol

#501
20200147130
2020-05-14

Food supplements for use in the prophylaxis and treatment of migraine

#502
20200138942
2020-05-07

Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer

#503
20200138900
2020-05-07

ANTIMICROBIAL FUSION PEPTIDES

#504
20200138700
2020-05-07

Hypotonic microbicidal formulations and methods of use

#505
20200115356
2020-04-16

Modulation of Bacterial Quorum Sensing With Synthetic Ligands

#506
20200113866
2020-04-16

Methods for treating obesity

#507
20200093855
2020-03-26

ENHANCED IMMUNE RESPONSE UPON TREATMENT WITH NITRIC OXIDE

#508
20200093851
2020-03-26

Glycan therapeutics and related methods thereof

#509
20200093845
2020-03-26

Glycan therapeutics and related methods thereof

#510
20200093832
2020-03-26

Methods and compositions for the inhibition of PIN1

#511
20200093794
2020-03-26

Methods, agents, and compositions for the treatment of acute myeloid leukemia

#512
20200093742
2020-03-26

Combination HIV therapeutic

#513
20200087372
2020-03-19

Acylated glucagon analogue

#514
20200087274
2020-03-19

Sulfonamide analogues of galiellalactone

#515
20200085784
2020-03-19

METHODS TO TREAT FIBROSIS, NASH, AND NAFLD

#516
20200085733
2020-03-19

Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces

#517
20200079853
2020-03-12

T REGULATORY CELLS AND USES THEREOF

#518
20200072832
2020-03-05

Methods and Systems for Modulating Hormones and Related Methods, Agents and Compositions

#519
20200069719
2020-03-05

Edible Energy Composition

#520
20200069712
2020-03-05

Pharmaceutical compounds and uses thereof

#521
20200069703
2020-03-05

CHEMICAL ENTITIES THAT KILL SENESCENT CELLS FOR USE IN TREATING AGE-RELATED DISEASE

#522
20200069628
2020-03-05

Methods and compositions for preventing and treating auditory dysfunctions

#523
20200069621
2020-03-05

Glutarate compounds for treating ischemia-reperfusion injuries

#524
20200063098
2020-02-27

USE OF N-BUTYLIDENEPHTHALIDE IN DOPAMINERGIC PROGENITOR CELL TRANSPLANTATION

#525
20200062726
2020-02-27

Treprostinil derivative compounds and methods of using same

#526
20200056183
2020-02-20

Targeted nanocarriers for the administration of immunosuppressive agents

#527
20200055835
2020-02-20

USE OF TRICYCLIC SESQUITERPENE LACTONES IN THE TREATMENT OF OBESITY AND RELATED DISEASES AND NON-THERAPEUTIC TREATABLE CONDITIONS

#528
20200054599
2020-02-20

Compositions comprising a compound of the avermectin family for the treatment and/or prevention of hand eczema

#529
20200046689
2020-02-13

PIM kinase inhibitors in combination with RNA splicing modulators/inhibitors for treatment of cancers

#530
20200038482
2020-02-06

COMPOSITIONS AND METHODS OF IMPROVED WOUND HEALING

#531
20200030443
2020-01-30

METHODS OF TREATING LUNG CANCER WITH A PD-1 AXIS BINDING ANTAGONIST, A PLATINUM AGENT, AND A TOPOISOMERASE II INHIBITOR

#532
20200030285
2020-01-30

Methods and compositions for delivering mycophenolic acid active agents to non-human mammals

#533
20200030280
2020-01-30

Andrographolide derivatives and method of using the same for treatment or prevention of fibrosis

#534
20200023066
2020-01-23

Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof

#535
20200009110
2020-01-09

Method for treating an allergic disease

#536
20200000718
2020-01-02

Solid Oral Pharmaceutical Compositions for Isoxazoline Compounds

#537
20190388555
2019-12-26

Di-substituted maleic amide linker for antibody drug conjugating and preparation method and use thereof

#538
20190388403
2019-12-26

Combinations to treat cancer

#539
20190388388
2019-12-26

Parthenolide and its derivative for use in the treatment of axonal damage

#540
20190381002
2019-12-19

Non-aromatic difluoro analogues of resorcylic acid lactones

#541
20190374489
2019-12-12

Oral pharmaceutical formulation for weight loss, diabetes and related disorders

#542
20190365706
2019-12-05

Dosing regimens of PKC activators

#543
20190359966
2019-11-28

Reprogramming urokinase into an antibody-recruiting anticancer agent

#544
20190359585
2019-11-28

SYNTHESIS OF RESORCYLIC ACID LACTONES USEFUL AS THERAPEUTIC AGENTS

#545
20190358336
2019-11-28

Cell internalizing compounds

#546
20190358303
2019-11-28

TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED HUMAN ALPHA-L-IDURONIDASE (IDUA)

#547
20190358257
2019-11-28

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#548
20190358198
2019-11-28

USE OF OVATODIOLIDE FOR PREPARING A COMPOSITION FOR INHIBITING PROTEIN SYNTHESIS OF GASTRIC HELICOBACTER PYPORI

#549
20190352272
2019-11-21

Bridged bicycloalkyl-substituted aminothiazoles and their methods of use

#550
20190351055
2019-11-21

Methods for Treating Bone-Related Disorders

#551
20190350898
2019-11-21

METHODS AND COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE

#552
20190343854
2019-11-14

Pharmaceutical composition for preventing or treating cancer

#553
20190338289
2019-11-07

Compositions and methods for reactivating latent immunodeficiency virus

#554
20190336540
2019-11-07

TREATMENT OF KRABBE DISEASE WITH UMBILICAL CORD BLOOD TRANSPLANTION (UCBT) AND INCREASED GALACTOCEREBROSIDASE (GALC) EXPRESSION

#555
20190336528
2019-11-07

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#556
20190321496
2019-10-24

AGENTS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH EXTRACELLULAR MATRIX TURNOVER

#557
20190321450
2019-10-24

Composition and method for improving sleep duration and quality

#558
20190321370
2019-10-24

Preservation of immune response during chemotherapy regimens

#559
20190314329
2019-10-17

Cdc7 kinase inhibitors and uses thereof

#560
20190314295
2019-10-17

Methods of treating skin with aromatic skin-active ingredients

#561
20190307894
2019-10-10

Endoplasmic reticulum-targeting nanovehicles and methods for use thereof

#562
20190307818
2019-10-10

NOVEL ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE

#563
20190307757
2019-10-10

Edible energy composition

#564
20190298762
2019-10-03

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#565
20190298679
2019-10-03

Methods of cancer treatment

#566
20190292172
2019-09-26

Bryostatin compounds and methods of preparing the same

#567
20190290630
2019-09-26

Combination therapy including an MDM2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers

#568
20190290621
2019-09-26

COMPOSITIONS AND METHODS FOR TREATING HIV-1 LATENCY

#569
20190282601
2019-09-19

PHARMACEUTICAL COMPOSITIONS FOR TREATING EBOLA VIRUS DISEASE

#570
20190282598
2019-09-19

Edible energy composition

#571
20190282566
2019-09-19

Use of Flibanserin in the treatment of obesity

#572
20190275118
2019-09-12

Agents directed against a cis RGMa/neogenin interaction or lipid rafts and use of the same in methods of treatment

#573
20190269797
2019-09-05

GENE TRANSFER COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES

#574
20190269648
2019-09-05

USE OF ARTEMISININ FOR TREATING TUMORS INDUCED BY ONCOGENIC VIRUSES AND FOR TREATING VIRAL INFECTIONS

#575
20190262449
2019-08-29

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

#576
20190262309
2019-08-29

Enhanced Gene Delivery to Natural Killer Cells, Hematopoietic Stem Cells and Macrophages

#577
20190262297
2019-08-29

Neprilysin inhibitors

#578
20190255109
2019-08-22

Methods of use for CAR T cells

#579
20190247309
2019-08-15

SELF-EMULSIFYING LIPID COMPOSITIONS

#580
20190247228
2019-08-15

Ophthalmic drug delivery method

#581
20190240275
2019-08-08

Extracts of , methods for preparation and use thereof

#582
20190231741
2019-08-01

Methods of treating disorders with glycosylation defective proteins

#583
20190224237
2019-07-25

Methods of use for CAR T cells

#584
20190216932
2019-07-18

Controlled drug release liposome compositions and methods thereof

#585
20190216770
2019-07-18

PHARMACEUTICAL PREPARATIONS

#586
20190209683
2019-07-11

Biophotonic compositions, methods, and kits for inhibiting and disrupting biofilms

#587
20190209632
2019-07-11

Pharmaceutical Composition for Preventing and Treating Alpha Herpes Virus Infection, Containing, As Active Ingredient, Elaeocarpus Sylvestris Extract or Fraction Thereof

#588
20190209521
2019-07-11

METHODS OF STIMULATING CELLULAR GROWTH, SYNAPTIC REMODELING AND CONSOLIDATION OF LONG TERM MEMORY

#589
20190209520
2019-07-11

PHARMACOLOGICAL TREATMENT OF COGNITIVE IMPAIRMENT

#590
20190201377
2019-07-04

METHODS AND COMPOSITIONS FOR TREATMENT OF LIPID STORAGE DISORDERS

#591
20190201375
2019-07-04

Methods and compositions for delivering mycophenolic acid active agents to non-human mammals

#592
20190201366
2019-07-04

Ketone bodies and ketone body esters as blood lipid lowering agents

#593
20190201357
2019-07-04

Glutarate compounds for treating ischemia-reperfusion injuries

#594
20190201332
2019-07-04

Soft chewable pharmaceutical products

#595
20190201318
2019-07-04

Composition for combating the signs of ageing of the skin and hair and nails

#596
20190194222
2019-06-27

Bryoid compositions, methods of making and use thereof

#597
20190192562
2019-06-27

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#598
20190192561
2019-06-27

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#599
20190192479
2019-06-27

Immunomodulator

#600
20190185442
2019-06-20

Dehydroleucodine derivatives and uses thereof